Phase solubility studies on oral antidiabetic drugs with β-cyclodextrin and HP - β cyclodextrin

International Journal of PharmTech Research

Volumn 1, Issue 4, 2009, Pages 1632-1637

  Prameela Rani, A ^a   Siva Teja, P ^a   Archana, N ^a   Bala Sekaran, C ^b  

^a KVSR SIDDHARTHA COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

^b Jagarlamudi Kuppuswamy Choudary College   (India)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BETA CYCLODEXTRIN; GLIMEPIRIDE; NATEGLINIDE; REPAGLINIDE;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE;

EID: 77953471012     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. rd ed., Pharmaceutical press, London, 2002, pp 333, 334, 322.
2. The Merck Index, 13rd ed., Merk Research Laboratories, White House Station, 2001, pp 6445, 8218, 4453.
3. Thompson D.O., Crit. Rev. Ther. Drug Carrier Syst., 1997, 14, 1.
4. Fernances C.M., Teresa V.M. and Veiga F.J., Eur. J. Pharm. Sci., 2002, 15, 79.
5. Kamada M. et al., J. Control. Release, 2002, 82, 407.
6. Chowdary K.P.R., Int. J. Pharma. Excip., 2003, 2, 70.
7. Higuchi T. and Connors K.A., Adv. Anal. Chem. Instr., 1965, 4,117.